Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7339 p262
5 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Contractors want legal advice from the PSNC

Pharmacy contractors have called on the Pharmaceutical Services Negotiating Committee to give legal advice on service level agreements and contracts.

Proposing a motion to that effect at this week’s local pharmaceutical committees’ conference in London, Gareth McCague (Leicester LPC) said that primary ccare trusts were trying to avoid responsibility and pass all liability for NHS services to contractors. They were requiring full indemnity for any consequences arising from NHS services and minimum insurance of £10m.

“These clauses ensure that there are no circumstances whatsoever where primary care trusts might be liable for harm caused by defective protocols that might have been prepared by PCT managers or pharmaceutical advisers,” Mr McCague said.

He added that Leicester PCT’s pharmaceutical adviser had agreed that contractors should not be responsible for the acts or omissions of the PCT but had been over-ruled by a PCT manager.

The motion was carried without dissent.

Concern was also expressed over the prolonged roll-out expected for the electronic transmission of prescriptions (ETP) from prescribers to pharmacies and from pharmacies to the Prescription Pricing Authority.

Calling on the PSNC to ensure that ETP was introduced without delay, Gary Jones (Berkshire LPC) said that the interim paper-based system that would be required for repeat dispensing was a particularly unappealing prospect. He was further concerned that some PCTs would not bother with it, leading to patients having access to repeat dispensing services in only some areas. This would financially disadvantage their pharmacies because they would be denied the additional dispensing fees associated with repeats.

There was no opposition to Mr Jones’s motion.

Other motions accepted by the conference called on the PSNC not to enter into partnerships with external organisations, such as education providers, without a transparent tendering process and to try to persuade the Department of Health to take steps to ensure that prescribers could not direct prescriptions to pharmacies of their own choice.

PSNC chief executive Sue Sharpe said that these were both PSNC policy. She added that she believed the DoH to be opposed to prescription direction.

Back to Top


©The Pharmaceutical Journal